RG

Roman Galetto

CE Cellectis: 6 patents #4 of 21Top 20%
Pfizer: 1 patents #101 of 358Top 30%
Overall (2019): #16,752 of 560,194Top 3%
7
Patents 2019

Issued Patents 2019

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
10517896 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Laurent POIROT, Andrew M. Scharenberg +1 more 2019-12-31
10426795 Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cells Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Laurent POIROT, Andrew M. Scharenberg +1 more 2019-10-01
10378026 RNA based method to obtain stably integrated retroviral vectors Andrew M. Scharenberg, Julianne Smith 2019-08-13
10363270 Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapy Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Laurent POIROT, Andrew M. Scharenberg +1 more 2019-07-30
10316101 BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy 2019-06-11
10294304 Chimeric antigen receptors targeting B-cell maturation antigen Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Alexandre Juillerat +6 more 2019-05-21
10286007 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Laurent POIROT, Andrew M. Scharenberg +1 more 2019-05-14